Article info

Music medicine to improve the tolerability of onabotulinumtoxinA injections for chronic migraine: an open-label prospective cohort study

Authors

  • Jason Ray Department of Neurology, Alfred Health, Melbourne, Victoria, AustraliaDepartment of Neuroscience, Monash University, Clayton, Victoria, AustraliaDepartment of Neurology, Austin Health, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  • Subahari Raviskanthan Department of Neurology, Alfred Health, Melbourne, Victoria, AustraliaDepartment of Neurology, The Royal Melbourne Hospital, Parkville, Victoria, AustraliaDepartment of Neuroophthalmology, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jason Ray; j.ray{at}alfred.org.au
View Full Text

Citation

Ray J, Raviskanthan S
Music medicine to improve the tolerability of onabotulinumtoxinA injections for chronic migraine: an open-label prospective cohort study

Publication history

  • Accepted September 3, 2023
  • First published September 26, 2023.
Online issue publication 
September 26, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.